Evidence map›Paper›PMID 34215344›Full record

ArticleStem cell research & therapy2021

Sox9-expressing cells promote regeneration after radiation-induced lung injury via the PI3K/AKT pathway.

Shuang Chen, Kang Li, Xinqi Zhong, Ganping Wang, Xiaocheng Wang, Maosheng Cheng, Jie Chen, Zhi Chen, Jianwen Chen, Caihua Zhang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Silicosis: from pathogenesis to therapeutics.Frontiers in pharmacology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Shuang Chen *Center for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Kang Li *Center for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Xinqi Zhong *Department of Neonatology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Ganping WangCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Xiaocheng WangCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Maosheng ChengCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Jie ChenCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Zhi ChenCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Jianwen ChenCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Caihua ZhangCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Gan XiongDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510030, China.
Xiuyun XuDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510030, China.
Demeng ChenCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. chendm29@mail.sysu.edu.cn.
Heping LiCenter for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. liheping@mail.sysu.edu.cn.
Liang PengOncology Department, Chinese PLA General Hospital, Beijing, 100000, China. pengliang@301hospital.com.cn.
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNChinese PLA General Hospital · CNGuangzhou Medical University · CNStomatology Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiation-induced lung injury (RILI) is considered one of the most common complications of thoracic radiation. Recent studies have focused on stem cell properties to obtain ideal therapeutic effects, and Sox9 has been reported to be involved in stem cell induction and differentiation. However, whether Sox9-expressing cells play a role in radiation repair and regeneration remains unknown.

methodsWe successfully obtained Sox9

resultsIn our study, we demonstrated that Sox9-expressing cells promote the regeneration of lung tissues and that ablation of Sox9-expressing cells leads to severe phenotypes after radiation damage. In addition, analysis of an online scRNA-Seq dataset revealed that the PI3K/AKT pathway is enriched in Sox9-expressing cells during lung epithelium regeneration. Finally, the AKT inhibitor perifosine suppressed the regenerative effects of Sox9-expressing cells and the AKT pathway agonist promotes proliferation and differentiation.

conclusionsTaken together, the findings of our study suggest that Sox9-expressing cells may serve as a therapeutic target in lung tissue after RILI.

Indexed as

Lung InjuryRadiation InjuriesSOX9 Transcription FactorAnimalsCell DifferentiationCell ProliferationLungMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionSuppressor Factors, ImmunologicPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktregeneration and tolerance factorSOX9 Transcription FactorSuppressor Factors, Immunologic

Identifiers

PMID34215344
PMCPMC8254240
OpenAlexW3135751868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.